Tradestie Institutional Equity Comparison Engine
SGHT vs VVOS โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
SGHT Overall Edge
SGHT Captures Institutional Edge (3โ0 Pillars ยท 7โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Sight Sciences, Inc. Common Stock (SGHT) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, SGHT trades at N/M Forward P/E with -20.2% operating margin (+25.2% YoY revenue) versus VVOS at N/M Forward P/E and -107.9% operating margin (+34.9% YoY). In options structure, SGHT sits in CONSOLIDATION (8th %ile IV; Dealer Gamma Walls on Pro) against VVOS sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
SGHT N/M vs VVOS N/M Fwd P/E
Growth & Margin Winner
SGHT
Op Margin -20.2% vs -107.9% ยท YoY +25.2% vs +34.9%
Momentum & Technical Winner
SGHT
1Y +46.9% vs -97.7% ยท 52W Pos 83% vs 0%
Options & Structure Winner
SGHT
CONSOLIDATION (8th %ile IV) vs BREAKDOWN (N/A IV)
SGHT
NASDAQ
Sight Sciences, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$10.18
-4.14% 1D
Market Cap
$590.2M
1M Return
+11.99%
1Y Return
+46.9%
Forward P/E
N/M
Unified AI Score
53.2 / 100
HOLD
Tech 39.0
Fund 54.0
Flow 70.0
Mom 60.0
VVOS
NASDAQ
Vivos Therapeutics, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$0.05
-5.1% 1D
Market Cap
$1.9M
1M Return
-59.25%
1Y Return
-97.71%
Forward P/E
N/M
Unified AI Score
36.4 / 100
SELL
Tech 25.0
Fund 35.0
Flow 50.0
Mom 30.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
SGHT +46.9%
VVOS -97.71%
Spread: +144.61 pp (SGHT Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | SGHT Revenue | VVOS Revenue | SGHT Op. Margin | VVOS Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | N/A | $10M | N/A | -92.8% | VVOS |
| FY2020 | $30M | $10M | -116.5% | -92.1% | VVOS |
| FY2021 | $50M | $20M | -105.2% | -120.7% | SGHT |
| FY2022 | $70M | $20M | -117.7% | -156.2% | SGHT |
| FY2023 | $80M | $10M | -70.7% | -125.3% | SGHT |
| FY2024 | $80M | $20M | -63.3% | -74.3% | SGHT |
| FY2025 | $80M | $20M | -48.0% | -114.1% | SGHT |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | SGHT | VVOS | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $590.2M | $1.9M | Larger Scale | SGHT |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +25.2% | +34.9% | Higher Growth | VVOS |
| Operating Margin (TTM) Profitability | -20.2% | -107.9% | Higher Margin | SGHT |
| Net Profit Margin Profitability | -32.1% | -121.8% | Higher Margin | SGHT |
| Return on Equity (ROE) Capital Efficiency | -50.1% | -8585.3% | Higher ROE | SGHT |
| 52-Week Range Position Momentum | 83% ($3โ$12) | 0% ($0โ$3) | Stronger Trend | SGHT |
| Beta / 30D Volatility Risk Regime | 1.09ฮฒ ยท 48% Vol | 1.70ฮฒ ยท 111% Vol | Lower Realized Risk | SGHT |
| Unified Institutional Score Composite Signal | 53.2 / 100 (HOLD) | 36.4 / 100 (SELL) | Higher Composite | SGHT |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full SGHT vs VVOS Buy Guide
SGHT
CONSOLIDATION
37d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
8th %ile
IV Regime
Compressed (<25th %ile)
VVOS
BREAKDOWN
113d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither SGHT nor VVOS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.